March 22, 2022
The results from the “Right Drug, Right Dose, Right Time: Using Genomic Data to Individualize Treatment” (RIGHT 10K) study strongly suggest that preemptive testing could benefit nearly every patient at some point, particularly when the testing extends beyond DNA variants already known to influence drug metabolism.
October 8, 2014
By Sam Smith
The final day of the Individualizing Medicine 2014 Conference kicked off with one of the pioneers of genomics taking the stage. Having founded the Baylor College of Medicine Human Genome Sequencing Center in 1997, Richard Gibbs led one of the five main groups that completed the Human Genome Project. Gibbs discussed his past, present and […]
Tags: Alexander Parker, Baylor College of Medicine, ceci connolly, Center for Individualized Medicne, Christopher Corless, Conference, DNA, EU-PACT, genome, genomics, Human Genome Sequencing Center, individualized medicine